养老院居民临终前β受体阻滞剂的停用情况
这项回顾性队列研究纳入2016年死亡且死前1年服用口服β受体阻滞剂的长期养老院居民,描述临终前1年β受体阻滞剂停用情况及相关因素。结果显示68.6%居民在生命最后45天仍在用药,临床医生感知预后不良者停药更早。
要点
- 68.6%的养老院居民在生命最后45天仍继续使用β受体阻滞剂。
- 有无心脏诊断者的β受体阻滞剂停用模式无差异。
- 临床医生感知预后不良或死亡指数升高者停药更早。
核心结论
- β受体阻滞剂在养老院居民生命最后一年仍被普遍处方。
- 临床医生感知预后有限者停药更早,改善预后判断可能有助于减少临终多重用药。
主要发现
- 平均年龄84.1岁,69.2%为女性。
- 60,573人(68.6%)在生命最后45天仍使用β受体阻滞剂。
- 57,880人(65.6%)有至少1个心脏诊断。
- 仅5,239人(5.9%)死亡指数升高,16,798人(19.0%)被感知为预后不良。
- 有无心脏诊断者的β受体阻滞剂停用模式无差异。
关键数值与推荐
- β受体阻滞剂停用定义为按Medicare Part D索赔记录,药物在手中断≥45天。
- 共病来自Chronic Condition Warehouse,其他特征来自Minimum Data Set。
临床怎么用
- 对养老院临终居民应评估β受体阻滞剂继续使用的获益与风险。
- 临床医生感知预后有限时,可更早考虑停用β受体阻滞剂以减少多重用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given limited life expectancy of nursing home (NH) residents, harms of continuing beta-blockers (BBs) may outweigh clinical benefits. Our objective was to describe beta-blocker discontinuation for NH residents during the last year of life, and identify characteristics associated with earlier discontinuation. METHODS: This was a retrospective cohort study that included all long-stay residents in fee-for-service Medicare who died in 2016 and were prescribed oral BBs 1 year before death. Beta-blocker discontinuation was defined as a gap in medication on hand for ≥45 days per Medicare Part D claims, measured from the last date drug was on hand. Comorbidities were obtained from Chronic Condition Warehouse, and other characteristics from the Minimum Data Set. Kaplan-Meier curves were used to describe time to first discontinuation. Findings were stratified by cardiac diagnoses, perceived life expectancy of <6 months, or elevated mortality index. RESULTS: Eighty-eight thousand two hundred and eighty-four residents were prescribed ≥1 daily BB 12 months before death. Mean age was 84.1 years and 69.2% were female. Of these, 60,573 residents (68.6%) remained on a BB in the last 45 days of life, and 57,880 residents (65.6%) had ≥1 cardiac diagnosis. Only 5239 residents (5.9%) had elevated mortality index, whereas 16,798 residents (19.0%) had perceived poor prognosis. In the last year of life, there was no difference in beta-blocker discontinuation pattern between residents with and without cardiac diagnoses. Residents with perceived poor prognosis and elevated mortality index discontinued BBs earlier. For example, mean time until discontinuation among residents with poor perceived prognosis was 245 versus 279 days in residents without such prognosis (p < 0.0001). CONCLUSIONS: BBs are commonly prescribed to NH residents in the final year of life. Overall, discontinuation occurs earlier in residents for whom clinicians perceive limited life expectancy, suggesting that improved prognostication may offer an important opportunity to reduce polypharmacy toward end of life.
引用
- Lee DS, Zullo AR, Lee Y, et al. Discontinuation of beta-blockers among nursing home residents at end of life. J Am Geriatr Soc. 2021. PMID: 34669190. doi:10.1111/jgs.17493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。